News Daily News Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients Todd Neale August 01, 2016
News Conference News TVT 2016 Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes Michael O'Riordan June 16, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Daily News When Problems Arise With Prosthetic Heart Valves, Multimodality Imaging Is Needed, Say European Guidelines Todd Neale May 06, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2016 Shelley Wood April 29, 2016
News Features Where Theory Meets Practice: Getting to the Heart of the Heart Team Yael L. Maxwell March 30, 2016
News Daily News MVARC Document Offers Template for Mitral Valve Therapeutics Research Todd Neale July 16, 2015
News Daily News El Documento MVARC Fija el Escenario para la Investigación Terapéutica de la Válvula Mitral Todd Neale July 16, 2015
News Daily News Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years July 07, 2015
News Daily News El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años July 07, 2015
News Daily News Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery Caitlin E. Cox June 15, 2015
News Daily News For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs July 25, 2013
News Daily News En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida July 25, 2013
News Daily News El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos Yael L. Maxwell July 12, 2013
News Daily News FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies L.A. McKeown October 14, 2011